质量即生命 — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

成为合作伙伴
ALIBEZUTIFA
Rx
肿瘤学 & 血液学

ALIBEZUTIFA

贝组替凡 (Belzutifan)
Generic (INN)
贝组替凡 (Belzutifan)
Strength
40 mg
Packaging
90 片/瓶。
Indication
ALIBEZUTIFA 适用于治疗需要针对相关肾细胞癌（RCC）、中枢神经系统（CNS）血管母细胞瘤或胰腺神经内分泌肿瘤（pNET）进行治疗且无需立即手术的 von Hippel-Lindau（VHL）病成年患者。
Registration No.
To be added
Package Insert
English & Lao (PDF)
Documents
Registration certificateTo be added
Medicine safety & reporting

More in 肿瘤学 & 血液学

View all →
ALIACATINIB
ALIACATINIB
阿卡替尼 (Acalabrutinib)
ALIREVMENI 160mg
ALIREVMENI 160mg
枸橼酸瑞伏美尼 (Revumenib citrate)
ALIQUZATINI 26.5mg
奎扎替尼 (Quizartinib)
ALIENTRECTINIB
ALIENTRECTINIB
恩曲替尼 (Entrectinib)
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文